Key Highlights

  • Net sales rose 7% to USD 390.8 million in the fiscal first quarter ended September 30, 2026, up 5% sequentially, with organic growth of 3% across all verticals.
  • Diluted EPS fell to USD 0.11 from USD 0.40, while adjusted diluted EPS was USD 0.25 against USD 0.49, as a higher tax charge and selling costs weighed.
  • Medical sales climbed 14% to USD 115.7 million, with 9% organic growth, helped by the recently acquired Helvoet Polymer Technologies.
  • Fiscal 2027 guidance was reiterated, with net sales now expected at the high end of USD 1,535 million to USD 1,560 million.

Sales Growth Returns, Led by Medical and Helvoet

Kimball Electronics (NASDAQ:KE) announced fiscal first-quarter 2027 results on November 4, 2026. Net sales of USD 390.8 million rose from USD 365.6 million, with Automotive up 4% to USD 170.5 million, Industrial up 5% to USD 104.6 million and Medical up 14%. The company is a contract manufacturer offering electronics Manufacturing services and contract development and manufacturing for medical customers, with plants in the United States, China, India, Mexico, Europe and Thailand. The CEO said organic growth was in line with expectations and driven by a high single-digit increase in Medical. The Helvoet Polymer Technologies tuck-in contributed to the reported gain, and sales rose 5% from the prior quarter. Automotive remains the largest vertical at 44% of sales, followed by Medical at 29% and Industrial at 27%.

Why Profit Fell Even as Sales Grew

Gross Margin held at 7.9% of sales, but selling and administrative expenses rose to USD 18.1 million, or 4.6% of sales, from USD 13.1 million, or 3.5%. Operating Income fell to USD 12.4 million from USD 14.5 million, a 3.2% margin against 4.0%. Adjusted Operating Margin was 4.3% versus 4.8%. Interest expense rose to USD 3.5 million, and the provision for taxes was USD 5.2 million on pretax income of USD 7.8 million, an effective rate of about 66% (calculated). Net Income was USD 2.6 million against USD 10.1 million. The release does not explain the tax rate.

Cash Outflow, Higher Debt and Guidance at the High End

Operating activities used USD 19.3 million of cash versus USD 8.1 million provided a year earlier, and investing used USD 109.7 million, while financing provided USD 114.0 million. Debt totaled USD 235.7 million against cash of USD 72.8 million, with borrowing capacity of USD 198.0 million. The company repurchased 127,000 shares for USD 3.1 million. Cash conversion days were 82, equaling a multiyear low. Guidance also calls for adjusted operating income of 4.4% to 4.7% of sales and Capital spending of USD 50 million to USD 60 million. The call is scheduled for November 5, 2026.

Where Things Stand

Yes, sales grew, but profit did not follow. Kimball Electronics (NASDAQ:KE) returned to top-line growth with a 7% rise, helped by Helvoet and 14% Medical growth, while GAAP EPS dropped to USD 0.11 on higher selling costs, interest and taxes. Guidance was reiterated, with sales at the high end of the range, so the year's margin target of 4.4% to 4.7% still requires the adjusted margin of 4.3% to improve. Watch cash generation, integration of Helvoet and the November 5 call.